Summer is here and it is a good time to assess if your reimbursement teams are tracking 2021 payer market trends and strategizing for market access. Do your drugs fall into the specialty tier category? If so, you may need to know about the new “second” specialty tier. Do you know if your clinical outcome strategies can support market access? For more details on these topics from May, click here to read the June newsletter.
Like what you see? Join our mailing list to receive our newsletter and be the first to know news on reimbursement trends and success cases for our clients as soon as they happen.